B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CSNK1A1

MOLECULAR TARGET

casein kinase 1 alpha 1

UniProt: P48729NCBI Gene: 145225 compounds

CSNK1A1 (casein kinase 1 alpha 1) is targeted by 25 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CSNK1A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1sb 2035804.92136
2seliciclib4.91135
3alvocidib4.5291
4ruxolitinib4.2368
5bosutinib4.0858
6bi 25364.0154
7quizartinib3.9953
8bms 3870323.4731
9cgs 159433.4731
10iodotubercidin3.3026
11galunisertib2.9418
12milciclib2.7715
13azd 54382.7114
14kw 24492.6413
15pyrvinium2.4811
16ic2612.309
17su 0148132.208
18y 399832.208
19encorafenib2.208
20cyc 1162.087
21tg100 1152.087
22uprosertib1.956
23sel 120 free base1.956
24Sorafenib0.691
25sp6001250.691

About CSNK1A1 as a Drug Target

CSNK1A1 (casein kinase 1 alpha 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 25 compounds with documented CSNK1A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CSNK1A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.